Clinical Trial Update: Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating monotherapy and combination regimens for nonalcoholic steatohepatitis (NASH) completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-15